HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masayoshi Arai Selected Research

Prostatic Neoplasms (Prostate Cancer)

7/2014Marine spongian sesquiterpene phenols, dictyoceratin-C and smenospondiol, display hypoxia-selective growth inhibition against cancer cells.
11/2010Hypoxia-selective growth inhibition of cancer cells by furospinosulin-1, a furanosesterterpene isolated from an Indonesian marine sponge.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masayoshi Arai Research Topics

Disease

21Neoplasms (Cancer)
04/2024 - 05/2004
7Starvation
04/2024 - 01/2016
7Hypoxia (Hypoxemia)
03/2019 - 11/2010
6Pancreatic Neoplasms (Pancreatic Cancer)
04/2022 - 01/2017
2Sarcoma (Soft Tissue Sarcoma)
12/2015 - 11/2010
2Prostatic Neoplasms (Prostate Cancer)
07/2014 - 11/2010
1Colorectal Neoplasms (Colorectal Cancer)
11/2023
1Colonic Neoplasms (Colon Cancer)
11/2023
1Central Nervous System Diseases (CNS Diseases)
10/2022
1Parkinson Disease (Parkinson's Disease)
10/2022
1Pneumonia (Pneumonitis)
01/2022
1Chronic Disease (Chronic Diseases)
01/2022
1Inflammation (Inflammations)
01/2022
1Osteosarcoma (Osteogenic Sarcoma)
08/2014
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2009
1Neuroblastoma
06/2009
1Aspiration Pneumonia
03/2007

Drug/Important Bio-Agent (IBA)

10Growth InhibitorsIBA
01/2020 - 04/2014
9Glucose (Dextrose)FDA LinkGeneric
04/2024 - 01/2016
4smenospondiolIBA
03/2019 - 07/2014
3furospinosulin-1IBA
01/2016 - 11/2010
3dictyoceratin-CIBA
12/2015 - 07/2014
2LuciferasesIBA
11/2023 - 01/2022
2epidithiodiketopiperazineIBA
06/2021 - 01/2020
2SesquiterpenesIBA
03/2019 - 07/2014
2PhenolsIBA
03/2019 - 07/2014
2EstersIBA
12/2015 - 07/2014
2Indicators and Reagents (Reagents)IBA
10/2004 - 05/2004
1cordycepinIBA
11/2023
1Monoamine Oxidase (MAO)IBA
10/2022
1Dopamine (Intropin)FDA LinkGeneric
10/2022
1Cytotoxins (Cytolysins)IBA
04/2022
13- hydroxy- 4- prenyl- 5- methoxystilbene- 2- carboxylic acidIBA
04/2022
1NLR ProteinsIBA
01/2022
1Silicon Dioxide (Silica)FDA LinkGeneric
01/2022
1asteltoxinIBA
01/2022
1InflammasomesIBA
01/2022
1oridoninIBA
01/2022
1Neuroprotective AgentsIBA
01/2022
1Mitochondrial Proton-Translocating ATPases (Mitochondrial ATP Synthase)IBA
01/2022
1secalonic acidIBA
03/2020
1xanthoneIBA
03/2020
1trichodermamide AIBA
01/2020
1aspergillazine AIBA
01/2020
1Endoplasmic Reticulum Chaperone BiPIBA
10/2018
1Carbolines (Beta-Carbolines)IBA
10/2018
1Proteins (Proteins, Gene)FDA Link
10/2018
1PolyketidesIBA
01/2017
1Halogenated Diphenyl EthersIBA
01/2017
1N-methylniphatyne AIBA
01/2016
1AlkaloidsIBA
01/2016
1lens epithelium-derived growth factorIBA
01/2016
1Hydroxyl RadicalIBA
12/2015
1AmidesIBA
12/2015
1Alkenes (Olefins)IBA
12/2015
1xylarianaphthol-1IBA
08/2014
1Phenol (Carbolic Acid)FDA Link
07/2014
1ligudentatolIBA
06/2014
1Alkynes (Acetylenes)IBA
04/2014
1tenuifolin diterpeneIBA
01/2011
1PD 128042IBA
07/2009
1AcetylcholinesteraseIBA
06/2009
1boromycinIBA
10/2004
1Bleomycin (Blenoxane)FDA LinkGeneric
10/2004
1simaomicin alphaIBA
05/2004

Therapy/Procedure

3Therapeutics
01/2022 - 12/2020
2Oral Administration
04/2014 - 11/2010
1Total Parenteral Nutrition
03/2007